Opaleye Management Inc. Journey Medical Corp Transaction History
Opaleye Management Inc.
- $418 Million
- Q2 2025
A detailed history of Opaleye Management Inc. transactions in Journey Medical Corp stock. As of the latest transaction made, Opaleye Management Inc. holds 95,000 shares of DERM stock, worth $707,750. This represents 0.16% of its overall portfolio holdings.
Number of Shares
95,000
Previous 95,000
-0.0%
Holding current value
$707,750
Previous $682,000
-0.0%
% of portfolio
0.16%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding DERM
# of Institutions
61Shares Held
7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.8 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$8.58 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.44 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$4.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$1.95 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $86.4M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...